Curcumin Derivatives As Potential Inhibitors For Breast Cancer Treatment: Molecular Docking, SwissADME and ProTox Analysis
Journal of the Indian Chemical Society · 2026-11 · 103227
DOI: 10.1016/j.jics.2026.103227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Indian Chemical Society, 2026-11. Verfasst von Rahul Sharma und 2 weiteren Autor:innen. Die Arbeit nennt 73 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sharma, R., Debbarma, E., & Ghanta, S. (2026). Curcumin Derivatives As Potential Inhibitors For Breast Cancer Treatment: Molecular Docking, SwissADME and ProTox Analysis. Journal of the Indian Chemical Society, 103227. https://doi.org/10.1016/j.jics.2026.103227
Vancouver
Sharma R, Debbarma E, Ghanta S. Curcumin Derivatives As Potential Inhibitors For Breast Cancer Treatment: Molecular Docking, SwissADME and ProTox Analysis. Journal of the Indian Chemical Society. 2026:103227. doi:10.1016/j.jics.2026.103227
BibTeX
@article{Sharma2026,
author = {Sharma, Rahul and Debbarma, Ernest and Ghanta, Susanta},
title = {Curcumin Derivatives As Potential Inhibitors For Breast Cancer Treatment: Molecular Docking, SwissADME and ProTox Analysis},
journal = {Journal of the Indian Chemical Society},
year = {2026},
pages = {103227},
doi = {10.1016/j.jics.2026.103227}
}
EUVIMED